CN Patent

CN114025751A — 用于治疗乙型肝炎病毒感染的组合物和方法

Assigned to Anhui Ronghang Biotechnology Development Co ltd · Expires 2022-02-08 · 4y expired

What this patent protects

本发明公开了一种用于治疗HBV感染的药物组合物，该药物组合物包含秋水仙碱和CYP3A4/P‑gp抑制剂。本发明还公开了用于治疗HBV感染的相关方法、用途和药盒。

USPTO Abstract

本发明公开了一种用于治疗HBV感染的药物组合物，该药物组合物包含秋水仙碱和CYP3A4/P‑gp抑制剂。本发明还公开了用于治疗HBV感染的相关方法、用途和药盒。

Drugs covered by this patent

Patent Metadata

Patent number
CN114025751A
Jurisdiction
CN
Classification
—
Expires
2022-02-08
Drug substance claim
No
Drug product claim
No
Assignee
Anhui Ronghang Biotechnology Development Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.